ICON Named Enterprise & Finance Firm of the 12 months and One in every of Forbes’ Finest Employers for Variety4 min read
ICON kick begins the primary half of 2022 with a string of prestigious trade awards recognising healthcare intelligence work and workers, as independently judged by friends worldwide
DUBLIN, Could 23, 2022–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world supplier of drug and machine growth and commercialisation companies to pharmaceutical, biotechnology, medical machine, and authorities organisations, has been recognised with quite a lot of prestigious enterprise and trade awards in April 2022, together with Firm of the 12 months on the 2021 Enterprise & Finance Irish Enterprise Awards and Pharma Contract Companies Firm of the 12 months on the Pharma Trade Awards 2021.
That is the second time the healthcare intelligence firm has acquired the distinguished Firm of the 12 months accolade from the Enterprise and Finance Awards Programme, having beforehand received in 2016. Winners are chosen by an impartial panel of trade skilled judges, who assessment market place, operational and monetary achievements, firm tradition and Environmental, Social and Governance (ESG) components.
Having already been introduced as considered one of America’s Finest Giant Employers in 2022 by Forbes, ICON has additionally been recognised as considered one of America’s Finest Employers for Variety for the second 12 months operating. Inclusion is among the core values at ICON, and has been a substantial focus for the corporate as a part of its total ESG technique. Along with constructing key group teams throughout the enterprise, over the past 12 months devoted variety coaching has been rolled out to folks leaders to help them in creating a way of connection and belonging inside their groups.
Commenting on the corporate’s current success, Steve Cutler, CEO, ICON plc stated: “To be the recipient of those awards is exceptionally gratifying as we develop and evolve our enterprise to be the healthcare intelligence companion of alternative. Quite a few vital areas of focus are mirrored in these successes – our dedication to supporting our shoppers and enhancing sufferers’ lives; being an employer of alternative and offering alternative to all of our folks; and the best way through which we function alongside our give attention to creating new and modern options to what we do and the way we do it. Most importantly, these awards actually replicate the distinctive expertise that we now have right here at ICON, proper throughout our enterprise.”
Further trade awards and recognition
In April, ICON received two Stevie® Awards in The twentieth Annual American Enterprise Awards®. It acquired a Silver award within the Cloud Utility/Service class for ARCADES, its subsequent technology knowledge integration instrument, and a Bronze award within the Enterprise or Aggressive Intelligence Answer class for IcoNex, which allows larger connection between key opinion leaders working in the identical therapeutic space. Greater than 230 professionals worldwide participated within the judging course of to pick out this 12 months’s Stevie Award winners.
Additional success for ICON got here within the 2022 CRO Management Awards, the place it was recognised within the Compatibility (Huge Pharma) class. Profitable CROs are chosen by means of neutral market analysis based mostly on suggestions from sponsor corporations that utilise their outsourcing companies.
Barry Balfe, President, ICON Pharma Options commented: “Being a companion of alternative for our shoppers signifies that we collaborate with them and ship perception, we’re aware of their wants and we ship effectively and on time. This compatibility award is recognition that our shoppers not solely discover us simple to work with, however that we additionally help them in reaching their desired outcomes. That is massively constructive suggestions for our groups right here at ICON.”
The energy of ICON’s leaders has additionally been recognised. In March, Dr Nuala Murphy, President of Growth and Commercialisation Options, was introduced because the 2021 Chambers Eire InBusiness Businesswoman of the 12 months. Nuala’s staff is concentrated on delivering built-in options that allow shoppers to expedite the event of medication and gadgets and to drive the adoption of decentralised trials. She additionally leads the corporate’s approaches to extend affected person participation and variety in scientific trials. Nuala led the staff that delivered the pivotal part 3 Pfizer and BioNTech COVID-19 vaccine scientific trials.
“I’m honoured to obtain this award. It’s an acknowledgement of what we, as a staff, have been capable of obtain in pioneering new approaches to scientific analysis which are extra environment friendly and efficient, and that finally drive higher options for our shoppers and higher outcomes for sufferers. To be a part of leading edge, scientific analysis is massively rewarding. I’m pleased with what our groups at ICON have been capable of do to drive transformation in our trade.”
A full record of ICON’s trade awards may be considered at www.iconplc.com/awards.
About ICON plc
ICON is a world-leading healthcare intelligence and scientific analysis organisation. From molecule to medication, we advance scientific analysis offering outsourced growth and commercialisation companies to pharmaceutical, biotechnology, medical machine and authorities and public well being organisations. We develop new improvements, drive rising therapies ahead and enhance affected person lives. With headquarters in Dublin, Eire, ICON employed roughly 39,300 workers in 138 areas in 53 international locations as at March 31, 2022. For additional details about ICON, go to: www.iconplc.com.
View supply model on businesswire.com: https://www.businesswire.com/information/house/20220523005046/en/
Claire Quinn (GMT time zone)
Company Communications, ICON plc
+353 87 4066091
Weber Shandwick (PR adviser)
Lisa Henry (GMT time zone)